SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/30/14 Ziopharm Oncology Inc 10-Q 9/30/14 51:4.2M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 475K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 19K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 19K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K 33: R1 Document and Entity Information HTML 38K 24: R2 Balance Sheets HTML 102K 31: R3 Balance Sheets (Parenthetical) HTML 36K 35: R4 Statements of Operations HTML 45K 47: R5 Statement of Stockholders' Equity HTML 55K 25: R6 Statements of Cash Flows HTML 104K 30: R7 Business HTML 28K 22: R8 Summary of Significant Accounting Policies HTML 19K 16: R9 Recently Issued Accounting Pronouncements HTML 18K 48: R10 Restructuring HTML 24K 37: R11 Fair Value Measurements HTML 34K 36: R12 Net Loss per Share HTML 23K 41: R13 Related Party Transactions HTML 23K 42: R14 Commitments and Contingencies HTML 72K 40: R15 Warrants HTML 47K 43: R16 Common Stock HTML 19K 32: R17 Stock-Based Compensation HTML 55K 34: R18 Fair Value Measurements (Tables) HTML 30K 39: R19 Net Loss per Share (Tables) HTML 22K 51: R20 Warrants (Tables) HTML 48K 45: R21 Stock-Based Compensation (Tables) HTML 56K 27: R22 Business - Additional Information (Detail) HTML 19K 38: R23 Restructuring - Additional Information (Detail) HTML 40K 29: R24 Assets and Liabilities Measured at Fair Value on HTML 23K Recurring Basis (Detail) 14: R25 Potential Dilutive Shares Excluded from HTML 23K Computation of Diluted Net Loss Per Share (Detail) 46: R26 Related Party Transactions - Additional HTML 33K Information (Detail) 49: R27 Commitments and Contingencies - Additional HTML 233K Information (Detail) 19: R28 Number of Warrants Outstanding (Detail) HTML 20K 18: R29 Warrants - Additional Information (Detail) HTML 51K 20: R30 Assumptions Used In Binomial Valuation Model and HTML 28K Black-Scholes Valuation Model (Detail) 21: R31 Warrant Exercise (Detail) HTML 26K 23: R32 Common Stock - Additional Information (Detail) HTML 29K 12: R33 Stock-Based Compensation Expense on All Employee HTML 22K and Non-Employee Awards (Detail) 44: R34 Stock-Based Compensation - Additional Information HTML 45K (Detail) 26: R35 Fair Value of Stock Options Assumptions Using HTML 37K Black-Scholes Option Valuation Model (Detail) 28: R36 Stock Option Activity Under Stock Option Plan HTML 76K (Detail) 15: R37 Summary of Unvested Restricted Stock (Detail) HTML 40K 50: XML IDEA XML File -- Filing Summary XML 75K 11: EXCEL IDEA Workbook of Financial Reports XLSX 117K 17: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 527K 5: EX-101.INS XBRL Instance -- ziop-20140930 XML 796K 7: EX-101.CAL XBRL Calculations -- ziop-20140930_cal XML 109K 8: EX-101.DEF XBRL Definitions -- ziop-20140930_def XML 668K 9: EX-101.LAB XBRL Labels -- ziop-20140930_lab XML 945K 10: EX-101.PRE XBRL Presentations -- ziop-20140930_pre XML 741K 6: EX-101.SCH XBRL Schema -- ziop-20140930 XSD 132K 13: ZIP XBRL Zipped Folder -- 0001193125-14-389572-xbrl Zip 107K
Download this Microsoft® Excel® .xlsx workbook |